title: Cryptozoospermia with normal testicular function after allogeneic stem cell transplantation: a case report.
abstract: One of the most frequent consequences of allogeneic haemopoietic stem cell transplantation (allo-SCT) in both males and females is gonadal insufficiency. We report the case of a 27-year-old myelodysplastic male who developed azoospermia after allogeneic transplantation of haemopoietic stem cells from his HLA-identical sister. Post-transplant azoospermia was alternated with intermittent severe oligospermia. The patient had a normal endocrine pattern and evidence of mild chronic graft-versus-host disease (cGVHD). Normal intratesticular spermatogenesis was revealed by bilateral fine needle aspiration (FNA) cytology. Inflammation was evident at semen analysis, but no infection was detected by microbiological examination and sperm culture. These findings, together with the re-appearance of sperm cells at semen analysis after a low-dose immunosuppressive treatment, suggested the presence of cGVHD of the urogenital tract, causing a reversible obstruction of the spermatic tract and cryptozoospermia. This is the first case report documenting a severe impairment of sperm count because of a reversible obstruction of the seminal tract, likely caused by cGVHD, in a long-term survivor of allo-SCT with normal endocrine pattern. An important practical consequence of this case report is the fact that azoospermia was cured using low-dose immunosuppressive therapy, and this allowed us to avoid expensive stimulatory treatments with gonadotrophins, which remain, however, ineffective if the obstruction of spermatic tracts is not removed. A spontaneous uncomplicated pregnancy occurred in the partner of the patient 3 months after the corticosteroid treatment withdrawal.
authors.affiliation: Department of Molecular and Clinical Endocrinology and Oncology, Federico II, University of Naples, Naples, Italy. tauchman@unina.it
authors.forename: L
authors.initials: L
authors.lastname: Tauchmanovà
authors.forename: C
authors.initials: C
authors.lastname: Alviggi
authors.forename: C
authors.initials: C
authors.lastname: Foresta
authors.forename: I
authors.initials: I
authors.lastname: Strina
authors.forename: A
authors.initials: A
authors.lastname: Garolla
authors.forename: A
authors.initials: A
authors.lastname: Colao
authors.forename: G
authors.initials: G
authors.lastname: Lombardi
authors.forename: G
authors.initials: G
authors.lastname: De Placido
authors.forename: B
authors.initials: B
authors.lastname: Rotoli
authors.forename: C
authors.initials: C
authors.lastname: Selleri
mesh_terms: D000328:Adult; D053713:Azoospermia / Q000209:etiology*; D044963:Biopsy, Fine-Needle; D006086:Graft vs Host Disease / Q000188:drug therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007248:Infertility, Male / Q000209:etiology; D007371:Interferon-gamma / Q000097:blood; D016753:Interleukin-10 / Q000097:blood; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D013076:Sperm Count; D013737:Testis / Q000473:pathology / Q000502:physiology*; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha
chemical_list: D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D007371:Interferon-gamma; D011241:Prednisone